CapsoVision, IncCVEarnings & Financial Report
CapsoVision, Inc. is a medical technology firm specializing in the development and manufacturing of advanced capsule endoscopy systems and supporting diagnostic solutions. Its non-invasive gastrointestinal imaging products are supplied to hospitals, gastroenterology clinics and medical specialists across global markets, supporting more accurate detection of digestive diseases and improved patient care experiences.
CV Q3 FY2025 Key Financial Metrics
Revenue
$3.5M
Gross Profit
$1.9M
Operating Profit
$-8.0M
Net Profit
$-7.9M
Gross Margin
54.1%
Operating Margin
-226.7%
Net Margin
-223.9%
YoY Growth
N/A
EPS
$-0.17
CapsoVision, Inc Q3 FY2025 Financial Summary
CapsoVision, Inc reported revenue of $3.5M for Q3 FY2025, with a net profit of $-7.9M (-223.9% margin). Cost of goods sold was $1.6M, operating expenses totaled $9.9M.
Key Financial Metrics
| Total Revenue | $3.5M |
|---|---|
| Net Profit | $-7.9M |
| Gross Margin | 54.1% |
| Operating Margin | -226.7% |
| Report Period | Q3 FY2025 |
Revenue Breakdown
CapsoVision, Inc Q3 FY2025 revenue of $3.5M breaks down across 2 segments, led by Products at $2.5M (71.1% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products | $2.5M | 71.1% |
| Other | $1.0M | 28.9% |
CapsoVision, Inc Revenue by Segment — Quarterly Trend
CapsoVision, Inc revenue by segment across the last 2 reported quarters, showing how each business line (such as Products and Other) has evolved quarter over quarter.
| Segment | Q3 FY2025 | Q2 FY2025 |
|---|---|---|
| Products | $2.5M | $2.4M |
| Other | $1.0M | $962.0K |
CapsoVision, Inc Quarterly Revenue & Net Profit History
CapsoVision, Inc results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $3.5M | — | $-7.9M | -223.9% |
| Q2 FY2025 | $3.3M | — | $-4.6M | -139.5% |
Income Statement
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Revenue | $3.3M | $3.5M |
| YoY Growth | N/A | N/A |
Balance Sheet
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Assets | $9.5M | $25.7M |
| Liabilities | $4.9M | $5.2M |
| Equity | $-139.0M | $20.4M |
Cash Flow
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Operating CF | $-9.5M | $-5.7M |